Stockreport

TherapeuticsMD Announces Issuance of First Orange Book Listable U.S. Patent for ANNOVERA®

TherapeuticsMD, Inc.  (TXMD) 
NASDAQ:AMEX Investor Relations: ir.therapeuticsmd.com
PDF -Newly-issued patent provides U.S. patent protection for ANNOVERA® into 2039- BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative wo [Read more]